Association Between Toxic Effects and Survival in Patients With Cancer and Autoimmune Disease Treated With Checkpoint Inhibitor Immunotherapy. Academic Article uri icon

Overview

abstract

  • This cohort study analyzed the safety and efficacy of immune checkpoint inhibitors in patients with cancer and autoimmune disease, and examined whether immune-related toxic effects were associated with outcomes.

publication date

  • September 1, 2022

Research

keywords

  • Autoimmune Diseases
  • Neoplasms

Identity

PubMed Central ID

  • PMC9264212

Scopus Document Identifier

  • 85134594833

Digital Object Identifier (DOI)

  • 10.1001/jamaoncol.2019.5570

PubMed ID

  • 35797031

Additional Document Info

volume

  • 8

issue

  • 9